ENTITY

Zai Lab (9688 HK)

58
Analysis
Health Care • China
Zai Lab is an innovative, research-based, commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative products for oncology, immunology, neuroscience, and infectious diseases. The company has commercialized products such as Zejula, Optune, Qinlock, Nuzyra, and Vyvgart in China. Zai Lab was founded in 2014 and is headquartered in Shanghai, China, and Cambridge, Massachusetts, USA.
more
Company Event • 23 Oct 2026 20:00 • Upcoming
Add To Calendar

Investor update

Company Event • 05 Nov 2026 21:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 13 Nov 2026 21:00 • Upcoming
Add To Calendar

Study update

Company Event • 06 Aug 2026 20:00 • Latest

Q2 2026

Company Event • 17 Jun 2026 20:00

AGM 2026

x